en
ua
ru
de
pt
es
pl
fr
tr
fi
da
no
sv
en
EGW-NewsCS:GOTüm haberler.OpTic Gaming and FaZe Clan passed to the semifinal of ELEAGUE Season 2

OpTic Gaming and FaZe Clan passed to the semifinal of ELEAGUE Season 2

Bu makale aşağıdaki dillerde mevcuttur
0
0
2071

Yesterday, second matches for passing to the semifinals of ELEAGUE Season 2 with $1,100,000 prize pool ended. OpTic Gaming vs mousesports and FaZe Clan vs Virtus.pro fought for the place in semifinals.

In a match between OpTic Gaming and mousesports, the American team got the easy winning with 2:0 score (16:7 de_train; 16:11 de_cache). In a result, mousesports left the tournament taking 5-8 place and received $50,000 reward.

Chicken.gg

Ücretsiz mücevherler, artı günlük, haftalık ve aylık destekler!

Chicken.gg
CS:GO
Claim bonus
Farmskins

Şimdi kaydolun ve 1 ÜCRETSİZ VAKA kazanın

Farmskins
CS:GO
Claim bonus
CSFAIL

EKSTRA %10 PARA YATIRMA BONUSU + ÜCRETSIZ 2 ÇARK DÖNDÜRME

CSFAIL
CS:GO
Claim bonus

In another match, two European teams FaZe Clan and Virtus.pro competed for the passing to the next stage. Virtus.pro confidently took the first map, winning the game with 16:4 score on de_dust2. However, FaZe Clan managed to take the victory in the following two matches. The overall score of the game is 2:1 in FaZe Clan favor ((4:16 de_dust2; 16:10 de_overpass; 16:14 de_cache). Virtus.pro together with mousesports left the tournament in the quarterfinal and took 5-8 places with $50,000 reward.

Rosters of new semifinalists:

OpTic Gaming:

Keith «NAF» MarkovicWill «RUSH» WierzbaÓscar «mixwell» CañellasTarik «tarik» CelikPeter «stanislaw» Jarguz

FaZe Clan:

Håvard «rain» NygaardPhilip «aizy» AistrupFabien «kioShiMa» FieyAleksi «allu» JalliFinn «karrigan» Andersen

On December 3, at midnight and 05:00 the matches between semifinalists will take place. The teams to take 3-4 places will be determined as well as the teams that will compete for the main prize of $400,000.

Canlı bir yorum
Makaleyi beğiniz mi?
0
0

Yorum

ZIRVEYE
FREE SUBSCRIPTION ON EXCLUSIVE CONTENT
Receive a selection of the most important and up-to-date news in the industry.
*
*Only important news, no spam.
SUBSCRIBE
LATER
İçeriği ve reklamları kişiselleştirmek, sosyal medya özellikleri sunmak ve trafiği analiz etmek için çerezler kullanıyoruz.
Kişiselleştir
OK